[1] [1] U.S. Food and Drug Administration. Guidance for Industry PAT-A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance. New Hampshire Avenue: FDA, 2004.

[5] [5] WU Z S, SUI C L, XU B, et al. Journal of Pharmaceutical and Biomedical Analysis, 2013, 77: 16.

[17] [17] LI W L, Xing L H, Fang L M, et al. Pharmaceutical and Biomedical Analysis, 2010, 53: 350.

[18] [18] LI W L, QU H B. Pharmaceutical and Biomedical Analysis, 2010, 52(4): 425.

[23] [23] Jin Y, Wu Z Z, Liu X S, et al. Journal of Pharmaceutical and Biomedical Analysis, 2013, 77: 32.

[32] [32] International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use(ICH). ICH Q8(R2): Pharmaceutical Development. Geneva: ICH, 2009.

[37] [37] Sui C L, Wu Z S, Peng Y F, et al. International Journal of On-Line Engineering, 2003, 44.

[41] [41] Wu Y J, Jin Y, Li Y R, et al. Vibrational Spectroscopy, 2012, 58: 109.

[42] [42] Xiao X, Ma J F, Ge F H, et al. World Scientific, 2014, 7(4): 13500631.